Jiang Pi | Immunotherapy | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jiang Pi | Immunotherapy | Best Researcher Award

Assoc Prof Dr. Jiang Pi, School of Medical Technology, Guangdong Medical University, China

Assoc. Prof. Dr. Jiang Pi appears to be a strong candidate for the Best Researcher Award based on the following qualifications:

Publication profile

Research Excellence:

Dr. Jiang Pi has made significant contributions to the fields of biomaterials, nanotechnology, and targeted drug delivery, particularly in developing innovative therapies for tuberculosis and cancer. His work has resulted in numerous high-impact publications in leading journals, demonstrating a strong research output and expertise.

Recognition and Honors:

 Dr. Jiang has been listed among the world’s top 2% scientists for three consecutive years (2021-2023). This recognition highlights his influence and contribution to his field on a global scale.

Leadership and Editorial Roles:

As Vice Dean at Guangdong Medical University, Dr. Jiang shows leadership in academia. His editorial roles in high-impact journals like Pharmacological Research, Frontiers in Pharmacology, and others reflect his active involvement and recognition in the scientific community.

Postdoctoral and Academic Training:

His extensive training, including a postdoctoral research position at the University of Illinois, Chicago, provides a solid foundation for his research.

Scientific Funding and Projects:

 Dr. Jiang Pi has secured significant research funding, underscoring his capability to lead and manage research projects successfully.

Publication Top Notes  

  • 🦠 Roles of HIF-1α signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?
    Authors: Li, C., Wang, J., Xu, J.-F., Pi, J., Zheng, B.
    Source: Biochemical and Biophysical Research Communications, 2024, 711, 149920.
    📚
  • 🌿 Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury
    Authors: Jin, H., Zhao, Y., Yao, Y., Pi, J., Huang, G.
    Source: Antioxidants, 2024, 13(3), 282.
    📚 Cited by: 2
  • 🧠 Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
    Authors: Yao, H., Wang, X., Chi, J., Pi, J., Xu, J.-F.
    Source: Molecules, 2024, 29(5), 964.
    📚 Cited by: 1
  • 🧬 Zinc Oxide-Selenium Nanoparticles for Inhibiting the Proliferation of Porcine Reproductive and Respiratory Syndrome Virus
    Authors: Xu, Y., Li, Q., Chen, Y., Zhou, L., Liu, J.
    Source: ACS Applied Nano Materials, 2024, 7(4), pp. 3734–3747.
    📚 Cited by: 2
  • 💊 Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis
    Authors: Zhao, Y., Yao, Y., Fan, S., Huang, G., Jin, H.
    Source: Journal of Tissue Engineering, 2024, 15.
    📚
  • 🦠 Identification and Validation of Genes Related to Macrophage Polarization and Cell Death Modes Under Mycobacterium tuberculosis Infection
    Authors: Yang, Z., Wang, J., Pi, J., Zhao, Y., Wang, Y.
    Source: Journal of Inflammation Research, 2024, 17, pp. 1397–1411.
    📚
  • 🦠 Macrophage targeted iron oxide nanodecoys augment innate immunological and drug killings for more effective Mycobacterium Tuberculosis clearance
    Authors: Shen, L., Liao, K., Yang, E., Xu, J.-F., Pi, J.
    Source: Journal of Nanobiotechnology, 2023, 21(1), 369.
    📚 Cited by: 2
  • 📈 Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?
    Authors: Xia, J., Liu, Y., Ma, Y., Xu, J.-F., Pi, J.
    Source: Pharmaceutics, 2023, 15(8), 2096.
    📚 Cited by: 3

Conclusion

Dr. Jiang Pi’s profile demonstrates the qualifications, recognition, and impact necessary for consideration in the Best Researcher Award.

Roger KoggeEnang | Soil Science | Best Researcher Award

Posted on by ScienceFather

Dr. Roger Kogge Enang | Soil Science | Best Researcher Award

Dr. Gabriel Espinosa Carrasco, University of Dschang, Cameroon

Dr. Roger Kogge Enang is a strong candidate for the Best Researcher Award due to his extensive background and contributions in soil science and environmental research. Here’s why he stands out:

Publication profile

Orcid

Extensive Research Output:

Since 2016, Dr. Enang has been actively publishing, with at least two scientific articles per year. His research spans various critical areas in soil science, including soil classification, nutrient cycling, and pollution remediation.

Educational Background:

He holds a Ph.D. and MSc in Soil Science, and a BSc in Chemistry, with a specialization in environmental chemistry and soil fertility. His academic credentials underpin his solid research foundation.

Diverse Research Interests:

His research covers vital topics such as soil mineralogy, soil organic matter, and digital soil mapping. He has contributed significantly to understanding soil properties and their implications for agriculture and environmental management.

Professional Involvement:

Dr. Enang is an active member of several professional organizations, including the Cameroon Soil Science Society and the International Network on Soil Pollution. His roles in these organizations reflect his commitment to advancing the field.

Field and Laboratory Experience:

His practical experience includes extensive soil surveys, experimental design, and advanced laboratory analyses. This hands-on expertise enhances the applicability and impact of his research findings.

Notable Publications:

Dr. Enang has published numerous peer-reviewed articles in reputable journals, demonstrating his ability to contribute valuable knowledge to the scientific community.

Given his track record of impactful research, extensive publications, and professional dedication, Dr. Roger Kogge Enang is highly suitable for the Best Researcher Award.

 

Maryam Hosseini | Immunotherapy Award | Best Researcher Award

Posted on by ScienceFather

Dr. Maryam Hosseini | Immunotherapy Award | Best Researcher Award

Dr. Maryam Hosseini, Shiraz University of Medical Sciences, Iran

Dr. Maryam Hosseini is an Iranian immunologist specializing in immune-mediated diseases, cancer immunology, and therapy, based at the Trauma Research Center, Shiraz University of Medical Sciences. With a PhD in Immunology from Tarbiat Modares University, her research focuses on extracellular vesicles and non-coding RNAs in immune responses. She has published extensively and presented her work globally, including on colorectal cancer and COVID-19 immunology. Dr. Hosseini is skilled in a range of laboratory techniques and has contributed significantly to the field through her teaching and workshop participation. 🧬🔬

 

Publication profile

🔬 Education

Maryam’s research focuses on inflammation, cancer immunology, and immune therapy. Her doctoral thesis explored the role of exosome-enriched miRNA-34a from CT-26 cell lines in anti-tumor immune responses in colorectal cancer mouse models.

Awards

Maryam’s academic excellence is evident through numerous honors, including ranking first among MSc students and actively contributing to immunology committees in Iran.

🎓 Teaching

Maryam is also dedicated to education, having taught immunology courses at Azad University. Her commitment extends to organizing international congresses and workshops, enriching both scientific discourse and student learning.

Research Focus

Maryam Hosseini’s research focus spans across several critical areas in immunology and biotechnology 🧬. Her work prominently explores the use of nanoparticles in cancer immunotherapy, highlighting their potential as novel therapeutic agents. Additionally, she investigates CAR-modified T-cell therapies for cancer treatment, emphasizing advancements in personalized medicine. Amidst the COVID-19 pandemic, she contributed significantly to understanding immune responses and therapeutic challenges associated with the virus. Her studies also extend to the role of exosomes in tumor progression and immune modulation, showcasing her diverse contributions to both basic and applied immunological sciences. Maryam’s multidimensional approach underscores her commitment to advancing biomedical research with impactful implications.

 

Publication Top Notes